FTC Approves Final Administrative Consent Orders against Sellers of Deceptively Marketed CBD Products

Following a public comment period, the Federal Trade Commission has approved final administrative consent orders against six companies selling cannabidiol (CBD) products nationwide.

Metadata
Provider: 
FTCFTC
URL: 
https://www.ftc.gov/news-events/press-releases/2021/03/ftc-approves-final-administrative-consent-orders-against-sellershttps://www.ftc.gov/news-events/press-releases/2021/03/ftc-approves-final-administrative-consent-orders-against-sellers
Retrieved on: 
Friday, March 5, 2021
Information
Tags: 
Drugs, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Hemp, Consent decree, Federal Trade Commission, Organ systems, CBD
Summary
Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved final administrative consent orders against six companies selling cannabidiol (CBD) products nationwide.
  • In December 2020, the Commission announced its first law enforcement crackdown on deceptive claims in the growing market for CBD products.
  • The Commission votes approving final consent orders against Bionatrol Health, LLC and HempmeCBD were each 5-0.
  • The votes approving the final consent orders against Epichouse LLC (First Class Herbalist CBD); CBD Meds, Inc.; and Reef Industries, Inc. were each 4-0.
Copyright: 
2021 FTC. All Rights Reserved.